The structure-based design and subsequent chemical synthesis of novel,
urea-containing FKBP12 inhibitors are described. These compounds are
shown to disrupt the cis-trans peptidylprolyl isomerase activity of FK
BP12 with inhibition constants (K-i,K-app) approaching 0.10 mu M. Anal
yses of several X-ray crystal structures of FKBP12-urea complexes demo
nstrate that the urea-containing inhibitors associate with FKBP12 in a
manner that is similar to, but significantly different from, that obs
erved for the natural product FK506.